Elisabeth Sandoval Little

Insider Reports History

Location
Westlake Village, CA
Signature
/s/ Mutya Harsch, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Elisabeth Sandoval Little:

Form 4 holding Director

PROCEPT BioRobotics Corp

Security class
Stock Option (Right to Buy)
Shares / value
2,771
Estimated value
$11,519
Report date
10 Jun 2025
Price
$4.56
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Intersect ENT, Inc.

Security class
Stock Options (Right to buy)
Shares / value
0
Estimated value
Report date
13 May 2022
Price
$28.25
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Satsuma Pharmaceuticals, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
08 Jun 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Elisabeth Sandoval Little

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .